5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Alterations in the PI3K/Akt signaling pathway and association with outcome in invasive high-grade urothelial cancer (UC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Al-Ahmadie, H.; Janakiraman, M.; Ostrovnaya, I.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Bochner, B.; Bajorin, D. F.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Exploratory analysis of survival benefit and prior docetaxel (D) treatment in COU-AA-301, a phase III study of abiraterone acetate (AA) plus prednisone (P) in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Chi, K. N.; Scher, H. I.; Molina, A.; Logothetis, C.; Jones, R. J.; Staffurth, J.; North, S. A.; Vogelzang, N. J.; Saad, F.; Mainwaring, P. N.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Examining the management of muscle-invasive bladder cancer (MIBC) by medical oncologists (MO)
    Meeting Abstract

    Apolo, A. B.; Bochner, B.; Steinberg, S. M.; Bajorin, D. F.; Kelly, W. K.; Quinn, D. I.; Vogelzang, N. J.; Sridhar, S. S.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Association of single-nucleotide polymorphisms in BCL2L1 and TACC3 with response to bacillus Calmette-Guerin intravesical therapy in non-muscle-invasive bladder cancer
    Meeting Abstract

    Alanee, S.; Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Riches, J. C.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Genome sequencing identifies a basis for everolimus sensitivity
    Journal Article

    Iyer, G.; Hanrahan, A. J.; Milowsky, M. I.; Al-Ahmadie, H.; Scott, S. N.; Janakiraman, M.; Pirun, M.; Sander, C.; Socci, N. D.; Ostrovnaya, I.; more...
    Science (2012)

    Fulltext@MSK | Save
  • Association of reduction in serum androgens and change in serum PSA in patients treated with abiraterone acetate (AA): A subset analysis of the COU-AA-301 phase 3 randomized trial
    Meeting Abstract

    Ryan, C.; Peng, W. P.; Kheoh, T.; Scher, H. I.; Molina, A.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Growth rates of tumors with numerous histologies remain constant while patients are on therapy
    Meeting Abstract

    Stein, W. D.; Wilkerson, J.; Adesunloye, B.; Madan, R.; Bates, S. E.; Wells, S.; Dahut, W.; Ning, Y. M.; Zhuang, S. H.; Motzer, R. J.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Baseline serum adrenal androgens are prognostic and predictive of overall survival (OS) in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC): Results of the COU-AA-301 phase 3 randomized trial
    Meeting Abstract

    Ryan, C.; Li, J. H.; Kheoh, T.; Scher, H. I.; Molina, A.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Magnetic resonance spectroscopic imaging of lactate in LDH-A silenced metastatic breast tumors
    Meeting Abstract

    Rizwan, A.; Serganova, I.; Ni, X. H.; Thakur, S.; Zakian, K. L.; Blasberg, R.; Koutcher, J.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • A link between lactate dehydrogenase A, lactate and tumor phenotype identified by imaging
    Meeting Abstract

    Serganova, I.; Rizwan, A.; Ni, X. H.; Thakur, S.; Blasberg, R.; Koutcher, J.
    Cancer Research (2012)

    Fulltext@MSK | Save